Inferra AIResearch Tools

Inferra AI / Company / PAYS

Paysign, Inc.

PAYS · Financials

Last earnings Aug 5, 2026

Key results

Revenuequarter

$19.08 million

revenues of $19.08 million, up 33.1% from second quarter 2024 &middot

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Growthquarter

up 33.1%

revenues of $19.08 million, up 33.1% from second quarter 2024 &middot

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Net incomequarter

$1.39 million

net income of $1.39 million, up 99.1% from $697 thousand a year ago, while diluted

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

EPSquarter

$0.02

earnings per share was $0.02, versus $0.01 for second quarter 2024 &middot

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

revenue decreased 4.7% &middot

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

revenue increased 189.9% &middot

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

“We achieved record quarterly revenue of $19.1 million, expanded gross margins and more than doubled adjusted EBITDA to $4.5 million versus the same period last year.

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Net income rose 99% to $1.4 million, even after absorbing approximately $300,000 in one-time expenses tied to the late-quarter onboarding of 123 plasma centers.

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Total revenuequarter

33.1%

” 1 2025 Second Quarter Results The following additional details are provided to aid in understanding Paysign’s second quarter 2025 results versus second quarter 2024: · Total revenues increased 33.1%, or $4.75 million.

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

AI analysis

Q2 2025 · reported Aug 5, 2025

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Revenue · Q2 2025
$19.08M
EX-99 · Aug 5, 2025
EPS · Q2 2025
$0.02
EX-99 · Aug 5, 2025
Net income · Q2 2025
$1.39M
EX-99 · Aug 5, 2025

Headline figures

MetricQ2 2025Prior qtrYear ago
Revenue$19.08 million——
Growthup 33.1%——
Net income$1.39 million——
EPS$0.02——
Total revenue33.1%——

EX-99 · Aug 5, 2025

Guidance · company-stated

Direction: raised

No guidance located in the held release

Stated figure48%

“3 Million, Up 48%; Raises Full-Year Outlook Growth Driven by Continued Momentum in Plasma and Patient Affordability Businesses Mix Shift and Expense Discipline Continue to Drive Gross and Operating Margin Expansion Balance Sheet Supports Continued Investment and Growth Initiatives HENDERSON, Nev.”

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

The increase resulted primarily from an increase in net income from strong growth in our pharma patient affordability business offset by investment in our platform, the purchase of the assets of Gamma Innovation LLC (“Gamma”), the payment of accrued operating expenses from the prior year and the repurchase of 100,000 shares of common stock.

Level 1 assets and liabilities include debt and equity securities.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Paysign, Inc. Q2 2025 — revenues of $19.08 million, up 33.1% from second quarter 2024 &middot

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Guidance & outlook

No guidance located in the held release

Capital allocation

The increase resulted primarily from an increase in net income from strong growth in our pharma patient affordability business offset by investment in our platform, the purchase of the assets of Gamma Innovation LLC (“Gamma”), the payment of accrued operating expenses from the prior year and the repurchase of 100,000 shares of common stock.

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Level 1 assets and liabilities include debt and equity securities.

SEC original ↗Paysign, Inc. — 10-Q Quarterly report10-QAug 6, 2026

12 In determining the present value of lease payments at lease commencement date, the Company utilizes its incremental borrowing rate based on the information available, unless the rate implicit in the lease is readily determinable.

SEC original ↗Paysign, Inc. — 10-Q Quarterly report10-QAug 6, 2026

The average discount rate of 8% was based on the Company s estimated cost of debt.

SEC original ↗Paysign, Inc. — 10-Q Quarterly report10-QAug 6, 2026

Strategy & priorities

” “Looking ahead, we are executing on strategic initiatives to expand our plasma offerings with our suite of SaaS donor engagement technologies and scale operations to meet accelerating demand for our pharma patient affordability solutions.

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Gamma is a software and services company focusing on the blood and plasma collection industry that developed innovative solutions targeting donor engagement, retention and management.

SEC original ↗Paysign, Inc. — 10-Q Quarterly report10-QAug 6, 2026

Risks & headwinds

We caution that these statements are qualified by important risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements.

SEC original ↗Paysign, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025

Legal Proceedings 31 Item 1A.

SEC original ↗Paysign, Inc. — 10-Q Quarterly report10-QAug 6, 2026

Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company s financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions that could have a material effect on the reported amounts of the Company s financial position and results of operations.

SEC original ↗Paysign, Inc. — 10-Q Quarterly report10-QAug 6, 2026

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Arthur J. Gallagher & Co. (AJG) FinancialsSun Life Financial (SLF) FinancialsRaymond James Financial (RJF) FinancialsAflac (AFL) FinancialsING Group (ING) FinancialsNorthern Trust (NTRS) FinancialsCincinnati Financial (CINF) FinancialsCoinbase (COIN) Financials
Documents

Filings

31 documents

Earnings releases

14 documents

Presentations

0 documents

No presentations for Paysign, Inc. are held in this edition of the library.

Transcripts

0 documents

No transcripts for Paysign, Inc. are held in this edition of the library.

Mentioned by

1 company

Other tracked companies whose held documents mention Paysign, Inc. by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.